Baker & McKenzie Welcomes New Pharmaceutical Practice Leader in Mexico City

Wednesday, April 24, 2013

Baker & McKenzie announces that Christian Alejandro López-Silva joined the Firm as the head of its Pharmaceutical and Life Sciences legal practice. Dr. López-Silva brings more than 14 years of experience to the Mexican offices of the Firm where he will coordinate the various practices that are focused on the Pharmaceutical and Life Sciences industry, enriching with his experience the multidisciplinary team of professionals serving important companies in this industry in Mexico.

More >>

Tags:  Baker McKenzie | Mexico City

Baker & McKenzie Acts for Saudi Binladin Group on Landmark Sukuk

Wednesday, April 24, 2013

Baker & McKenzie recently acted for the Saudi Binladin Group in relation to a SAR 1.3 billion (US$347 million) sukuk al-ijara issued by SBG Sukuk Limited as an exempt offering in the Kingdom of Saudi Arabia. The innovative sukuk structure benefits from security over  prime real estate in Jeddah as well as a corporate guarantee from the Saudi Binladin Group.

More >>

Tags:  Baker McKenzie

Paul Hastings Represents Future Land in RMB1.5 Billion Senior Notes Offering

Wednesday, April 24, 2013

Paul Hastings, a leading global law firm, announced today that it represented Future Land Development Holdings Limited (“Future Land”), a leading Chinese property developer focused on developing quality residential and mixed-use projects and listed on the Hong Kong Stock Exchange, in a CNH high yield bond offering of senior notes (“Notes”) with an aggregate principal amount of RMB1.5 billion, due 2016.

More >>

Tags:  Paul Hastings, LLP | Hong Kong

Paul Hastings Represents Avalon Ventures in $495 Million Life Science Collaboration with GlaxoSmithKline

Wednesday, April 24, 2013

Paul Hastings, a leading global law firm, announced today that the firm represented Avalon Ventures, a San Diego-based venture capital fund, in its $495 million collaboration with global healthcare company GlaxoSmithKline (GSK) to fund and launch up to ten early-stage life sciences companies. While the technologies for the companies may come from anywhere in the world, the companies and their management and scientific teams will all be located in San Diego.

More >>

Tags:  Paul Hastings, LLP

Davis Polk – Taminco Corporation Initial Public Offering

Wednesday, April 24, 2013

Davis Polk advised Citigroup Global Markets Inc., Goldman, Sachs & Co., Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC as joint book-running managers of the several underwriters in connection with the initial public offering of 15,789,474 shares of common stock of Taminco Corporation at $15.00 per share for net proceeds to Taminco of approximately $223.8 million. The common stock is listed on the New York Stock Exchange under the symbol “TAM.”

More >>

Tags:  Davis Polk & Wardwell LLP | New York